Karachi: BF Biosciences Limited (BFBIO) announced a significant 102% growth in its FY24 revenue, reaching PkR3.7 billion compared to PkR1.8 billion in FY23. This growth was attributed to an 84% increase in volumes and an 18% rise in prices, with Antif...
The post BF Biosciences Limited Reports 102% Growth in Annual Revenue Amidst Strategic Expansions appeared first on Pakistan Business News.
Read More »
AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service